ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

ファーマコビジランスにおけるPRR/ROR×Caco-2細胞透過性アッセイ×
分野薬理学薬理学
系統Process / pipelineProcess / pipeline
提唱年20021989
提唱者Arne Melander and colleaguesIngrid Hidalgo
種類safety signal detectionabsorption screening
原典Szarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗
別名PRR, ROR, signal detection, adverse event monitoringCaco-2 assay, intestinal permeability, ADME screening
関連33
概要Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.
ScholarGateデータセット
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 2 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: Pharmacovigilance PRR/ROR · Caco-2 Permeability. 2026-06-19に以下より取得 https://scholargate.app/ja/compare